These compounds may interact with:
Glutamate receptor ionotropic, NMDA 2B
Potentially involved in: autism spectrum disorder; intellectual disability; epilepsy; alzheimer's disease; mental depression; melanoma; kidney cancer; carcinoma; skin cancer; large intestine cancer; schizophrenia; toxic encephalopathy; parkinson's disease; alcohol dependence; cerebrovascular disease; huntington's disease; autistic disorder; obsessive-compulsive disorder; encephalitis; bipolar disorder
Disease data sourced from Pharos.